Later that year, Abifadel and colleagues reported the discovery of 2 mutations in PCSK9 that resulted in familial hypercholesterolemia (FH), a genetic disease characterized by greatly increased levels of LDL-C and early onset of atherosclerosis and cardiovascular events [8]. Here, PCSK9 is linked to atherosclerosis.